Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Poor Prognosis
100%
Tumor Progression
100%
Ovarian Carcinoma
100%
Cyclin E
100%
Overexpression
25%
Late-onset
25%
Image Analysis
12%
Disease Progression
12%
Carcinoma
12%
Immunohistochemical Analysis
12%
Delayed Diagnosis
12%
Multivariate Analysis
12%
Tissue Microarray
12%
Disease Groups
12%
Independent Prognostic Factor
12%
Cyclin-dependent Kinase
12%
Poor Outcome
12%
Tumorigenesis
12%
Dysregulated
12%
Serous Carcinoma
12%
Cyclin
12%
Clear Cell
12%
Primary Ovarian Carcinoma
12%
Cystadenoma
12%
Microarray Technology
12%
Late Events
12%
High-grade Tumor
12%
Poorly Differentiated Carcinoma
12%
Reduced Survival
12%
Low Malignant Potential Tumor
12%
Suboptimal Cytoreduction
12%
Normal Ovary
12%
E Protein
12%
Ovarian Carcinogenesis
12%
Suboptimal Debulking
12%
Medicine and Dentistry
Tumor Progression
100%
Krukenberg Tumor
100%
Cyclin E
100%
Diseases
25%
Carcinogenesis
25%
Tumor
25%
Image Analysis
12%
Cell Cycle
12%
Carcinoma
12%
Disease Exacerbation
12%
Tissue Microarray
12%
Debulking
12%
Prognostic Factor
12%
Serous Carcinoma
12%
Clear Cell
12%
Cystadenoma
12%
Cyclin
12%
Cyclin-Dependent Kinase
12%
Multivariate Analysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Ovary Carcinoma
100%
Cyclin E
100%
Diseases
25%
Carcinoma
25%
Carcinogenesis
25%
Disease Exacerbation
12%
Cyclin Dependent Kinase
12%
Cycline
12%
Cystadenoma
12%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Cyclin E
100%
Carcinogenesis
25%
Cell Cycle
12%
Multivariate Analysis
12%
Cyclin-Dependent Kinase
12%
Tissue Microarray
12%
Cyclin
12%